This information is intended for UK healthcare professionals only.
This animation has been commissioned and funded by Pfizer Limited and developed in partnership with Guidelines in Practice. Pfizer Limited suggested the topic and presenter, and carried out full medical approval on all materials to ensure compliance with regulations. The presenter was paid an honorarium by Pfizer Limited. The views and opinions expressed in the animation are not necessarily those of Pfizer Limited, or of Guidelines in Practice, its publisher, advisers, or advertisers. No part of this animation may be reproduced in any form without the permission of the publisher.
Pfizer Limited has had no involvement with content on this webpage other than the animation and associated description.
Aims of this Guidelines in Practice animation
Do we need to change how we manage patients with chronic pain from osteoarthritis (OA)?
Presented by Professor David Walsh (Professor of Rheumatology, Pain Centre Versus Arthritis, University of Nottingham, Honorary Consultant Rheumatologist, Sherwood Forest Hospitals NHS Foundation Trust)
This animation is based on a real-world evidence study using data from the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES). Based on this retrospective, longitudinal cohort study in patients with moderate-severe chronic pain associated with OA, the animation:
- describes the total healthcare resource use and direct healthcare costs associated with moderate-severe pain in OA vs matched control cohort without OA
- describes the demographics and clinical characteristics of patients with moderate-severe pain in OA
- describes the management of moderate-severe pain in OA in both primary and secondary care settings.
Date of preparation: June 2021